The Chief Executive Officer of Moderna said that he anticipates people will need a second COVID-19 booster shot this fall as the vaccine’s efficacy wanes over the next few months.
Stephane Bancel, speaking at a Goldman Sachs-organized healthcare conference on Thursday, said Moderna is working on a booster shot focused on the omicron variant of COVID-19, however it’s unlikely that it will be available in the next two months.
“I still believe we’re going to need boosters in the fall of ’22 and forward,” Bancel said.
A new study from Israel showed that a fourth dose of the vaccine boosts antibodies five-fold, Israeli Prime Minister Naftali Bennett announced on Tuesday. The country has already begun dosing immunocompromised individuals.
Moderna announced during its third quarter earnings results that commercial booster market sales could reach $2 billion in the United States in 2022.
With Post Wires